Previous close | 24.13 |
Open | 25.01 |
Bid | 24.36 x 1000 |
Ask | 24.40 x 800 |
Day's range | 24.14 - 24.99 |
52-week range | 21.53 - 32.71 |
Volume | |
Avg. volume | 935,234 |
Market cap | 10.906B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 40.76 |
EPS (TTM) | 0.60 |
Earnings date | 01 May 2024 |
Forward dividend & yield | 0.75 (3.11%) |
Ex-dividend date | 01 Apr 2024 |
1y target est | 31.50 |
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip